#United States #New York #Class Action #Lead Plaintiff #Nutex Health

Reminder for Nutex Health Inc. Shareholders: Lead Plaintiff Deadline Approaches

The Gross Law Firm has issued an important notice to shareholders of Nutex Health Inc. (NASDAQ: NUTX), reminding them of the approaching deadline to seek lead plaintiff status in a significant class action lawsuit. Shareholders who acquired shares between August 8, 2024, and August 14, 2025, are particularly urged to take action before the October 21, 2025 deadline.

Allegations of Misleading Information

The lawsuit alleges several serious offenses attributed to the company's management. Specifically, it claims that Nutex Health made materially false and misleading statements during the class period. The allegations include:

1. Deceptive Practices: It is alleged that Nutex was engaged in unscrupulous activities through its third-party vendor, HaloMD. This vendor reportedly managed to secure favorable arbitration results through a coordinated scheme designed to defraud insurance companies.

2. Unsustainable Revenues: Given the said fraudulent practices, the revenues that Nutex derived from its dealings with HaloMD's independent dispute resolution (IDR) process were deemed unsustainable and not reflective of legitimate business activities.

3. Overstated Remediation Claims: Additionally, the company is accused of overstating how effectively it had addressed weaknesses in its internal financial controls. This lack of genuine remediation further compounded its fiscal reporting complications, leading to inaccuracies in how it accounted for stock-based compensation obligations.

4. Risks of Reporting Delays: The culmination of these factors indicates a rising likelihood that the company might face challenges in timely filing essential financial reports with the SEC. Consequently, Nutex's optimistic public statements regarding its financial health and future prospects have been called into question.

Next Steps for Affected Shareholders

Shareholders interested in pursuing a lead plaintiff status must act swiftly. Enrolling in the class action is essential for affected shareholders to remain informed and be part of potential recovery efforts. The registration process is straightforward and incurs no costs or obligations for the participants. After registration, shareholders will receive updates through specialized portfolio monitoring software regarding the developments of the case.

Why Choose The Gross Law Firm?

The Gross Law Firm stands out as a nationally recognized entity dedicated to safeguarding the rights of investors. Their commitment to ensuring ethical business practices and corporate accountability is evident through their relentless pursuit of justice for those who have suffered due to corporate deceit and malfeasance. By representing shareholders in this class action, the firm seeks to recover losses stemming from the alleged misleading conduct of Nutex.

Contact Information

For shareholders to engage in this matter, contact details for The Gross Law Firm are as follows:
Address: 15 West 38th Street, 12th Floor, New York, NY, 10018
Phone: (646) 453-8903
Email: [email protected]
Website: Nutex Class Action Information

This critical notice serves to inform all stakeholders of their rights and options moving forward. Ensuring your participation in such legal proceedings can have significant implications not just for recovery of losses, but for long-term corporate accountability by fostering a stringent oversight culture in business practices.